Hyderabad: The recent launch of drug Mounjaro (Tirzepatide) in India by US-based pharma company Eli Lilly has generated a lot of interest and hype due to its unique ability to be effective towards ...

US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight management and diabetes treatment. Offering a dual-action mechanism targeting ...

Eli Lilly's Mounjaro tirzepatide, a Type 2 diabetes and obesity drug, launched in India post-CDSCO approval. Aimed at public health gaps but costly for many. Mounjaro (tirzepatide), a breakthrough ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide ...

Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...

While many stayed mum about shedding drastic weight, stars like Oprah Winfrey were honest Dubai: With the arrival of Eli Lilly’s weight-loss drug Mounjaro in India today, the conversation around ...

Weight loss drugs such as Mounjaro help the body manage blood sugar more effectively, make one feel less hungry, and slow digestion, so the person feels full longer. Mounjaro, chemically known as ...

US pharma giant Eli Lilly's obesity management drug Mounjaro has now been launched in India. Interestingly, compared to the US, the price of Mounjaro in India will be one-fifth. Apart from obesity, ...

In a single-dose vial presentation Eli Lilly, a pharmaceutical firm has announced the launch of Mounjaro, following the authorization from the Central Drugs Standard Control Organization (CDSCO). The ...

India’s wait is over. The popular anti-obesity drug Mounjaro is finally here. The development comes after Eli Lilly received approval from India’s Central Drugs Standard Control Organisation (CDSCO).

Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling with obesity and diabetes. Priced between 3,500 and 4,375 rupees per vial, ...